The Atherectomy Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Directional, Orbital, Photo-Ablative, Rotational, Others), By Application (Peripheral Vascular, Cardiovascular, Neurovascular), By End-User (Hospitals, Surgical Centers, Ambulatory Care Centers, Research Laboratories, Others).
Atherectomy devices are medical instruments used to remove atherosclerotic plaque from blood vessels, particularly in the coronary and peripheral arteries, to restore blood flow and alleviate symptoms of ischemic heart disease and peripheral artery disease (PAD). In 2024, the field of atherectomy devices continues to advance with the development of next-generation devices, improved procedural techniques, and expanded indications for use in the treatment of complex arterial lesions. From rotational atherectomy systems and directional atherectomy catheters to laser atherectomy and orbital atherectomy devices, interventional cardiologists and vascular surgeons have access to a variety of tools to debulk and modify atherosclerotic plaque, tailored to the specific anatomical and clinical characteristics of each patient. Moreover, with advancements in imaging guidance, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), atherectomy procedures can be performed with greater precision and safety, enabling more effective plaque removal and minimizing the risk of procedural complications. By offering minimally invasive alternatives to traditional balloon angioplasty and stenting, atherectomy devices help improve long-term patency rates, reduce the need for repeat interventions, and enhance outcomes for patients with obstructive arterial disease, ultimately improving their quality of life and reducing the burden of cardiovascular morbidity and mortality.
A significant trend in the atherectomy devices market is the shift towards minimally invasive peripheral vascular interventions for the treatment of arterial plaque buildup and peripheral artery disease (PAD). As patients and healthcare providers seek alternatives to traditional open surgical procedures, there is a growing preference for minimally invasive techniques that offer reduced recovery times, shorter hospital stays, and improved patient outcomes. Atherectomy devices play a critical role in these interventions by facilitating the removal of atherosclerotic plaque from arterial walls, restoring blood flow, and improving limb perfusion in patients with PAD. This trend towards minimally invasive peripheral vascular interventions reflects a broader movement towards patient-centric care and the adoption of advanced technologies to address vascular diseases while minimizing procedural risks and complications.
The primary driver fueling the growth of the atherectomy devices market is the increasing prevalence of peripheral artery disease (PAD) and critical limb ischemia (CLI) globally. PAD and CLI are common vascular disorders characterized by the narrowing or blockage of arteries in the extremities, leading to reduced blood flow, tissue ischemia, and limb-threatening complications. With aging populations, rising rates of diabetes, and lifestyle factors contributing to vascular health issues, the incidence of PAD and CLI continues to rise, driving the demand for effective treatment options. Atherectomy devices offer minimally invasive alternatives to traditional surgical interventions, such as angioplasty and bypass surgery, providing targeted plaque removal and vessel preparation to restore arterial patency and improve limb perfusion in patients with PAD and CLI. This growing patient population drives the adoption of atherectomy devices by vascular specialists and interventional cardiologists seeking to optimize patient outcomes and preserve limb function in individuals with peripheral vascular disease.
A potential opportunity lies in innovation in device design and technology to enhance the performance, safety, and versatility of atherectomy devices for peripheral vascular interventions. With advancements in engineering, materials science, and catheter-based technologies, there is an opportunity to develop next-generation atherectomy devices that offer improved plaque removal efficiency, enhanced maneuverability, and reduced procedural risks. Innovations such as rotational atherectomy, orbital atherectomy, and laser atherectomy techniques enable physicians to address a broader range of lesion types, including calcified and fibrotic plaques, while minimizing trauma to surrounding tissues and preserving vessel integrity. Furthermore, the integration of imaging modalities, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enhances procedural guidance and facilitates accurate lesion assessment, enabling more precise treatment planning and execution. By investing in research and development efforts to advance atherectomy device technology, manufacturers can capitalize on opportunities to differentiate their products, expand their market presence, and address the evolving needs of physicians and patients in the peripheral vascular intervention space.
The fastest-growing segment in the Atherectomy Devices Market is Peripheral Vascular, primarily propelled by the escalating demand for minimally invasive procedures to treat peripheral artery disease (PAD) and other peripheral vascular conditions. Peripheral vascular atherectomy devices, including directional, orbital, rotational, and photo-ablative types, offer effective alternatives to traditional surgical interventions for removing atherosclerotic plaque from peripheral arteries. As patients increasingly seek less invasive treatment options that result in faster recovery times and reduced post-operative complications, healthcare providers, including hospitals, surgical centers, and ambulatory care centers, are embracing atherectomy devices for peripheral vascular applications. Additionally, advancements in device technology, such as improved navigation capabilities, enhanced precision, and reduced procedural time, further contribute to the segment's rapid growth. With the growing prevalence of peripheral vascular diseases and the continuous innovation in atherectomy device technology, the Peripheral Vascular segment is expected to maintain its robust growth momentum in the Atherectomy Devices Market.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Avinger Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cardiovascular Systems Inc, Cordis Corp, Koninklijke Philips N.V., Medtronic plc, Terumo Medical Corp
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Avinger Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cardiovascular Systems Inc
Cordis Corp
Koninklijke Philips N.V.
Medtronic plc
Terumo Medical Corp
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Atherectomy Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Atherectomy Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Atherectomy Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Atherectomy Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Atherectomy Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Atherectomy Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Atherectomy Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Atherectomy Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Atherectomy Devices Industry
4.2 Key Market Trends in Atherectomy Devices Industry
4.3 Potential Opportunities in Atherectomy Devices Industry
4.4 Key Challenges in Atherectomy Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Atherectomy Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Atherectomy Devices Market Outlook by Segments
7.1 Atherectomy Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
8 North America Atherectomy Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Atherectomy Devices Markets in 2024
8.2 North America Atherectomy Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Atherectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
9 Europe Atherectomy Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Atherectomy Devices Markets in 2024
9.2 Europe Atherectomy Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Atherectomy Devices Market Size Outlook by Segments, 2021-2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
10 Asia Pacific Atherectomy Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Atherectomy Devices Markets in 2024
10.2 Asia Pacific Atherectomy Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Atherectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
11 South America Atherectomy Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Atherectomy Devices Markets in 2024
11.2 South America Atherectomy Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Atherectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
12 Middle East and Africa Atherectomy Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Atherectomy Devices Markets in 2024
12.2 Middle East and Africa Atherectomy Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Atherectomy Devices Market size Outlook by Segments, 2021-2030
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Avinger Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cardiovascular Systems Inc
Cordis Corp
Koninklijke Philips N.V.
Medtronic plc
Terumo Medical Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Directional
Orbital
Photo-Ablative
Rotational
Others
By Application
Peripheral Vascular
Cardiovascular
Neurovascular
By End-User
Hospitals
Surgical Centers
Ambulatory Care Centers
Research Laboratories
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Atherectomy Devices Market is one of the lucrative growth markets, poised to register a 7.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Avinger Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cardiovascular Systems Inc, Cordis Corp, Koninklijke Philips N.V., Medtronic plc, Terumo Medical Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume